Статья
Неврологические и психические расстройства, ассоциированные с COVID-19
В статье представлен обзор научной литературы, клинических наблюдений, содержащий данные о патогенезе, особенностях неврологических проявлений и психических расстройств, осложнениях со стороны нервной системы при новой коронавирусной инфекции, иллюстрированный клиническими примерами. Неврологические нарушения возникают примерно у 36,4 % пациентов с COVID-19. В последнее время описаны тяжелый вирусный геморрагический энцефалит, токсическая энцефалопатия, острые демиелинизирующие поражения периферической нервной системы, острые нарушения мозгового кровообращения, расстройства в поведенческой и эмоциональной сфере. Несмотря на многочисленные публикации о поражении нервной системы, в контексте эпидемии COVID-19 остаются неясными вопросы патогенеза, наличия факторов риска, аргументированной связи неврологических расстройств с коронавирусной инфекцией. Несомненно, необходима систематизация накопленных данных о поражении нервной системы в период эпидемии COVID-19 для их использования в практической работе невролога, дальнейшей разработки оптимальной стратегии лечения и осуществления эффективных профилактических мероприятий.
1. Временные методические рекомендации. Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). Версия 6. Апрель 28, 2020. Министерство здравоохранения Российской Федерации.
2. Pérez CA. Looking ahead: The risk of neurologic complications due to COVID-19. Neurology: Clinical Practice. 2020.. doi:10.1212/CPJ.0000000000000836
3. Galougahi M, Ghorbani J, Bakhshayeshkaram M, Safavi Naeini A, Haseli S. Olfactory bulb magnetic resonance imaging in SARS-CoV-2-induced anosmia: the first report. Academic Radiology. 2020.. doi:10.1016/j.acra.2020.04.002
4. Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020.. doi:10.1016/j.bbi.2020.03.031
5. Nath A, Berger JR. Clinical neurovirology. Second edition. CRC Press; 2020. Р. 439–443.
6. Kuster G, Pfister O, Burkard T, Zhou Q, Twerenbold R, Haaf P et al. SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19? Eur Heart J. 2020.. doi:10.1093/eurheartj/ehaa235
7. Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020.. doi:10.1001/jamacardio.2020.0950
8. Machado C, Gutierrez J. Brainstem dysfunction SARS-CoV-2 infection can be a potential cause of respiratory distress. Preprints. 2020;2020040330.. doi:10.20944/preprints202004.0330.v1
9. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol.2020;77(6):683–690. doi:10.1001/jamaneurol.2020.1127
10. Asadi-Pooya A, Simani L. Central nervous system manifestations of COVID-19: a systematic review. J Neurol Sci. 2020; 413:116832. doi:10.1016/j.jns.2020.116832
11. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18:844–847. doi:10.1111/jth.14768
12. COVID-19 and coagulopathy: frequently asked questions. Input from Drs. AYY Lee, JM Connors, L Baumann Kreuziger, M Murphy, T Gernsheimer, Y Lin. Version 2.0; last updated April 14, 2020.. URL: https://www.hematology.org/covid-19/covid-19-and-coagulopathy
13. COVID-19 and VTE/anticoagulation: frequently asked questions. Input from Drs. L Baumann Kreuziger, A Lee, D Garcia, A Cuker, M Cushman, JM Connors. Version 2.1; last updated April 17, 2020.. URL: https://www.hematology.org/covid-19/covid-19-and-vte-anticoagulation
14. Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E. et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up. J Am Coll Cardiol. 2020.. doi:10.1016/j.jacc.2020.04.031
15. Временные методические рекомендации. Ведение пациентов с острыми нарушениями мозгового кровообращения в контексте пандемии COVID-19. Версия 1; Апрель 6, 2020. doi:10.1016/j.bbi.2020.04.077
16. Oxley T, Mocco J, Majidi S, Kellner C, Shoirah H, Singh P et al. Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med. 2020.. doi:10.1056/NEJMc2009787
17. Young K, Fairchild DG, Francesco LD. COVID-19: stroke in young adults/new presentation in kids/ACS admission. NEJM Journal Watch. Accessed May 6, 2020.. URL: https://www.jwatch.org/fw116590/2020/04/28/covid-19-strokeyoung-adults-new-presentation-kids-acs
18. Li Y, Wang M, Zhou Y, Chang J, Xian Y, Mao L. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. J Stroke. 2020.. doi:10.1016/j.jocn.2020.04.124
19. Needham E, Chou S, Coles A, Menon D. Neurological implications of COVID-19 infections. Neurocrit Care. 2020.. doi:10.1007/s12028-020-00978-4
20. Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B. COVID 19-associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology. 2020.. doi:10.1148/radiol.2020201187
21. Moriguchia T, Hariib N, Gotoa J, Haradaa D, Sugawaraa H, Takaminoa J et al. A first of meningitis/encephalitis associated with SARS-Coronavirus-2. Intern J Infect Dis. 2020;94:55–58. doi:10.1016/j.ijid.2020.03.062
22. Fung Wong P, Craik S, Newman P, Makan A, Srinivasan K, Crawford E et al. Lessons of the month 1: A case of rhombencephalitis as a rare complication of acute COVID-19 infection. Clin Med. 2020;20(3):1–2. doi:10.7861/clinmed.2020-0182
23. Filatov A, Sharma P, Hindi F, Espinosa P. Neurological complications of coronavirus disease (COVID-19): encephalopathy. Cureus. 2020;12(3): e7352. doi:10.7759/cureus.7352
24. Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020.. doi:10.1056/NEJMc2008597
25. Zhao H, Shen D, Zhou H, Liu J, Chenet S. Guillen-Barre syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet. 2020;19(5):383–384. doi:10.1016/S1474-4422(20)30109-5
26. Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni G et al. Guillain–Barré syndrome associated with SARSCoV-2. N Engl J Med. 2020.. doi:10.1056/NEJMc2009191
27. Gutierrez C, Mendez A, Rodrigo-Rey S, San PedroMurillo E, Bermejo-Guerrero L, Gordo-Mañas R et al. Miller Fisher syndrome and polyneuritis cranialis in COVID-19. Neurology. 2020.. doi:10.1212/WNL.0000000000009619
28. Dinkin M, Gao V, Kahan J, Bobker S, Simonetto M, Wechsler P et al. COVID-19 presenting with ophthalmoparesis from cranial nerve palsy. Neurology. 2020.. doi:10.1212/WNL.0000000000009700
29. Dong L, Bouey J. Public mental health crisis during COVID-19 Pandemic, China. Emerging infectious diseases. 2020;26(7).. doi:10.3201/eid2607.200407
30. Li W, Yang Y, Liu Z, Zhao Y, Zhang Q, Zhang L et al. Progression of Mental Health Services during the COVID-19 Outbreak in China. Int J Biol Sci. 2020;16(10):1732–1738. doi:10.7150/ijbs.45120
31. Schwati BJ. New Poll: COVID-19 Impacting mental well-being: American feeling anxious, especially for loved ones. APA News releases... URL: https://www.psychiatry.org/newsroom/news-releases/new-poll-covid-19-impacting-mental-well-being-americans-feeling-anxious-especially-for-loved-ones-older-adults-are-less-anxious
32. Rossi R, Socci V, Talevvi D, Mensi S, Niolu C, Pacitti F et al. COVID-19 pandemic and lockdown measure impact on mental health among the general population in Italy. МedRxiv preprint.. doi:10.1101/2020.04.09.20057802
33. Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020;395(10227):912–920. doi:10.1016/S0140-6736(20)30460-8
34. Gales S, Merchant RM, Lurie N. The mental health consequences of COVID-19 and physical distancing: the need for prevention and early intervention. JAMA Intern Med. 2020.. doi:10.1001/jamainternmed.2020.1562
35. Tubbs AS, Perlis ML, Basner M, Chakravorty S, Khader W, Fernandez F et al. Relationship of nocturnal wakefulness to suicide risk across months and methods of suicide. J Clin Psychiatry. 2020;81(2):19m12964. doi:10.4088/JCP.19m12964
36. Kang L, Li Y, Hu S, Chen M, Yang BX. The mental health of medical workers in Wuhan, China dealing with the 2019 novel coronavirus. Lancet Psychiatry. 2020;7(3):e14. doi:10.1016/S2215-0366(20)30047-X
37. Coronavirus disease 2019 (COVID-19) Situation report-45. World Health Organisation. March 5, 2020.. URL: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200305-sitrep-45-covid-19.pdf?sfvrsn=ed2ba78b_2